cholestyramine resin has been researched along with cardiovascular agents in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (cardiovascular agents) | Trials (cardiovascular agents) | Recent Studies (post-2010) (cardiovascular agents) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 17,645 | 1,480 | 6,891 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Löbel, P; Schrör, K; Steinhagen-Thiessen, E | 1 |
1 other study(ies) available for cholestyramine resin and cardiovascular agents
| Article | Year |
|---|---|
Cholestyramine treatment of type IIa hypercholesterolaemia normalizes platelet reactivity against prostacyclin.
Topics: Blood Platelets; Cardiovascular Agents; Cholestyramine Resin; Epoprostenol; Humans; Hyperlipoproteinemia Type II; Iloprost; Male; Platelet Aggregation; Thromboxane B2 | 1988 |